Qingdao Haier Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
April 28, 2021 at 04:47 am
Share
Qingdao Haier Biomedical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 413.627 million compared to CNY 266.831 million a year ago. Operating income was CNY 476.509 million compared to CNY 78.381 million a year ago. Net income was CNY 419.839 million compared to CNY 69.278 million a year ago. Basic earnings per share from continuing operations was CNY 1.32 compared to CNY 0.22 a year ago.
Qingdao Haier Biomedical Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of biomedical low-temperature storage products. The Company's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The Company's products are sold to domestic and overseas markets.